A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan

NCT00199290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Periodontitis

Interventions

DRUG: Trafermin (genetical recombination)

Sponsor

Kaken Pharmaceutical